Pergi ke luar talian dengan aplikasi Player FM !
MIRA Pharmaceuticals, Inc. Erez Aminov, CEO
Manage episode 373264159 series 2612480
MIRA is developing a new
molecular synthetic THC analog called MIRA1a, designed for the treatment of
adult patients with anxiety and cognitive decline, typically associated with
early-stage dementia.
MIRA’s initial focus will
be a dual path: potentially winning in traditional pain and anxiety markets as
well as the marijuana analog markets with a potentially safe and effective option if approved
by the FDA.
160 episod
Manage episode 373264159 series 2612480
MIRA is developing a new
molecular synthetic THC analog called MIRA1a, designed for the treatment of
adult patients with anxiety and cognitive decline, typically associated with
early-stage dementia.
MIRA’s initial focus will
be a dual path: potentially winning in traditional pain and anxiety markets as
well as the marijuana analog markets with a potentially safe and effective option if approved
by the FDA.
160 episod
Semua episod
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.